Red blood cells mediated delivery of 9-(2-phosphonylmethoxyethyl)adenine to primary macrophages: Efficiency, metabolism and activity against human immunodeficiency virus or herpes simplex virus

Carlo Federico Perno, Nadia Santoro, Emanuela Balestra, Stefano Aquaro, Alessandra Cenci, Giuseppe Lazzarino, Donato Di Pierro, Barbara Tavazzi, Jan Balzarini, Enrico Garaci, Settimio Grimaldi, Raffaele Caliò

Research output: Contribution to journalArticle

Abstract

Red blood cells (RBC) may act as selective carriers of drugs to macrophages, an important reservoir of viruses such as human immunodeficiency virus (HIV) and herpes simplex virus type 1 (HSV-1). We therefore assessed the incorporation of 9-(2-phosphonylmethoxyethyl)adenine (PMEA, a potent inhibitor of HIV and HSV-1) into RBC, its delivery to macrophages and its activity against HIV or HSV-1. Loading of PMEA in artificially aged opsonized RBC affords significant levels of intracellular PMEA. RBC metabolize PMEA to its active congener PMEA-diphosphate, although with low efficiency. Exposure of macrophages to RBC-encapsulated PMEA inhibits the replication of both HIV and HSV-1 (about 90% inhibition at the highest RBC:macrophages ratios) even if RBC were removed before virus challenge. By contrast, the antiviral activity of free PMEA removed before virus challenge was irrelevant at concentrations up to 150-fold higher than the 50% effective concentration (EC50). Finally, the antiviral effect of RBC-encapsulated PMEA correlates with PMEA levels in macrophages about 500-fold higher than those achieved by free PMEA (at concentrations 10-fold higher than the EC50). The efficacy of RBC-mediated delivery to macrophages of PMEA (and perhaps of compounds with shorter intracellular half-lives) warrants further studies in infectious diseases involving phagocytizing cells as main targets of the pathogen.

Original languageEnglish
Pages (from-to)153-164
Number of pages12
JournalAntiviral Research
Volume33
Issue number3
DOIs
Publication statusPublished - Feb 1997

Fingerprint

Simplexvirus
Erythrocytes
Macrophages
HIV
Human Herpesvirus 1
Viruses
Antiviral Agents
adefovir
Drug Carriers
Diphosphates
Communicable Diseases

Keywords

  • Erythrocytes
  • Herpes simplex virus type 1
  • Human immunodeficiency virus
  • Macrophages
  • PMEA

ASJC Scopus subject areas

  • Virology
  • Pharmacology

Cite this

Red blood cells mediated delivery of 9-(2-phosphonylmethoxyethyl)adenine to primary macrophages : Efficiency, metabolism and activity against human immunodeficiency virus or herpes simplex virus. / Perno, Carlo Federico; Santoro, Nadia; Balestra, Emanuela; Aquaro, Stefano; Cenci, Alessandra; Lazzarino, Giuseppe; Pierro, Donato Di; Tavazzi, Barbara; Balzarini, Jan; Garaci, Enrico; Grimaldi, Settimio; Caliò, Raffaele.

In: Antiviral Research, Vol. 33, No. 3, 02.1997, p. 153-164.

Research output: Contribution to journalArticle

Perno, Carlo Federico ; Santoro, Nadia ; Balestra, Emanuela ; Aquaro, Stefano ; Cenci, Alessandra ; Lazzarino, Giuseppe ; Pierro, Donato Di ; Tavazzi, Barbara ; Balzarini, Jan ; Garaci, Enrico ; Grimaldi, Settimio ; Caliò, Raffaele. / Red blood cells mediated delivery of 9-(2-phosphonylmethoxyethyl)adenine to primary macrophages : Efficiency, metabolism and activity against human immunodeficiency virus or herpes simplex virus. In: Antiviral Research. 1997 ; Vol. 33, No. 3. pp. 153-164.
@article{4c76c4eb818e468fb4a13032f249eda0,
title = "Red blood cells mediated delivery of 9-(2-phosphonylmethoxyethyl)adenine to primary macrophages: Efficiency, metabolism and activity against human immunodeficiency virus or herpes simplex virus",
abstract = "Red blood cells (RBC) may act as selective carriers of drugs to macrophages, an important reservoir of viruses such as human immunodeficiency virus (HIV) and herpes simplex virus type 1 (HSV-1). We therefore assessed the incorporation of 9-(2-phosphonylmethoxyethyl)adenine (PMEA, a potent inhibitor of HIV and HSV-1) into RBC, its delivery to macrophages and its activity against HIV or HSV-1. Loading of PMEA in artificially aged opsonized RBC affords significant levels of intracellular PMEA. RBC metabolize PMEA to its active congener PMEA-diphosphate, although with low efficiency. Exposure of macrophages to RBC-encapsulated PMEA inhibits the replication of both HIV and HSV-1 (about 90{\%} inhibition at the highest RBC:macrophages ratios) even if RBC were removed before virus challenge. By contrast, the antiviral activity of free PMEA removed before virus challenge was irrelevant at concentrations up to 150-fold higher than the 50{\%} effective concentration (EC50). Finally, the antiviral effect of RBC-encapsulated PMEA correlates with PMEA levels in macrophages about 500-fold higher than those achieved by free PMEA (at concentrations 10-fold higher than the EC50). The efficacy of RBC-mediated delivery to macrophages of PMEA (and perhaps of compounds with shorter intracellular half-lives) warrants further studies in infectious diseases involving phagocytizing cells as main targets of the pathogen.",
keywords = "Erythrocytes, Herpes simplex virus type 1, Human immunodeficiency virus, Macrophages, PMEA",
author = "Perno, {Carlo Federico} and Nadia Santoro and Emanuela Balestra and Stefano Aquaro and Alessandra Cenci and Giuseppe Lazzarino and Pierro, {Donato Di} and Barbara Tavazzi and Jan Balzarini and Enrico Garaci and Settimio Grimaldi and Raffaele Cali{\`o}",
year = "1997",
month = "2",
doi = "10.1016/S0166-3542(96)01011-X",
language = "English",
volume = "33",
pages = "153--164",
journal = "Antiviral Research",
issn = "0166-3542",
publisher = "Elsevier",
number = "3",

}

TY - JOUR

T1 - Red blood cells mediated delivery of 9-(2-phosphonylmethoxyethyl)adenine to primary macrophages

T2 - Efficiency, metabolism and activity against human immunodeficiency virus or herpes simplex virus

AU - Perno, Carlo Federico

AU - Santoro, Nadia

AU - Balestra, Emanuela

AU - Aquaro, Stefano

AU - Cenci, Alessandra

AU - Lazzarino, Giuseppe

AU - Pierro, Donato Di

AU - Tavazzi, Barbara

AU - Balzarini, Jan

AU - Garaci, Enrico

AU - Grimaldi, Settimio

AU - Caliò, Raffaele

PY - 1997/2

Y1 - 1997/2

N2 - Red blood cells (RBC) may act as selective carriers of drugs to macrophages, an important reservoir of viruses such as human immunodeficiency virus (HIV) and herpes simplex virus type 1 (HSV-1). We therefore assessed the incorporation of 9-(2-phosphonylmethoxyethyl)adenine (PMEA, a potent inhibitor of HIV and HSV-1) into RBC, its delivery to macrophages and its activity against HIV or HSV-1. Loading of PMEA in artificially aged opsonized RBC affords significant levels of intracellular PMEA. RBC metabolize PMEA to its active congener PMEA-diphosphate, although with low efficiency. Exposure of macrophages to RBC-encapsulated PMEA inhibits the replication of both HIV and HSV-1 (about 90% inhibition at the highest RBC:macrophages ratios) even if RBC were removed before virus challenge. By contrast, the antiviral activity of free PMEA removed before virus challenge was irrelevant at concentrations up to 150-fold higher than the 50% effective concentration (EC50). Finally, the antiviral effect of RBC-encapsulated PMEA correlates with PMEA levels in macrophages about 500-fold higher than those achieved by free PMEA (at concentrations 10-fold higher than the EC50). The efficacy of RBC-mediated delivery to macrophages of PMEA (and perhaps of compounds with shorter intracellular half-lives) warrants further studies in infectious diseases involving phagocytizing cells as main targets of the pathogen.

AB - Red blood cells (RBC) may act as selective carriers of drugs to macrophages, an important reservoir of viruses such as human immunodeficiency virus (HIV) and herpes simplex virus type 1 (HSV-1). We therefore assessed the incorporation of 9-(2-phosphonylmethoxyethyl)adenine (PMEA, a potent inhibitor of HIV and HSV-1) into RBC, its delivery to macrophages and its activity against HIV or HSV-1. Loading of PMEA in artificially aged opsonized RBC affords significant levels of intracellular PMEA. RBC metabolize PMEA to its active congener PMEA-diphosphate, although with low efficiency. Exposure of macrophages to RBC-encapsulated PMEA inhibits the replication of both HIV and HSV-1 (about 90% inhibition at the highest RBC:macrophages ratios) even if RBC were removed before virus challenge. By contrast, the antiviral activity of free PMEA removed before virus challenge was irrelevant at concentrations up to 150-fold higher than the 50% effective concentration (EC50). Finally, the antiviral effect of RBC-encapsulated PMEA correlates with PMEA levels in macrophages about 500-fold higher than those achieved by free PMEA (at concentrations 10-fold higher than the EC50). The efficacy of RBC-mediated delivery to macrophages of PMEA (and perhaps of compounds with shorter intracellular half-lives) warrants further studies in infectious diseases involving phagocytizing cells as main targets of the pathogen.

KW - Erythrocytes

KW - Herpes simplex virus type 1

KW - Human immunodeficiency virus

KW - Macrophages

KW - PMEA

UR - http://www.scopus.com/inward/record.url?scp=0031035735&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0031035735&partnerID=8YFLogxK

U2 - 10.1016/S0166-3542(96)01011-X

DO - 10.1016/S0166-3542(96)01011-X

M3 - Article

C2 - 9037372

AN - SCOPUS:0031035735

VL - 33

SP - 153

EP - 164

JO - Antiviral Research

JF - Antiviral Research

SN - 0166-3542

IS - 3

ER -